Cargando…
Predicting neoadjuvant chemotherapy benefit using deep learning from stromal histology in breast cancer
Neoadjuvant chemotherapy (NAC) is a standard treatment option for locally advanced breast cancer. However, not all patients benefit from NAC; some even obtain worse outcomes after therapy. Hence, predictors of treatment benefit are crucial for guiding clinical decision-making. Here, we investigated...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684483/ https://www.ncbi.nlm.nih.gov/pubmed/36418332 http://dx.doi.org/10.1038/s41523-022-00491-1 |